Summit Therapeutics Inc. announced on June 10, 2026, that it has withdrawn its previously announced proposed underwritten public offering of securities due to market conditions. Summit Therapeutics Inc. is a biotechnology company focused on developing and commercializing therapeutic solutions for oncology and infectious diseases.
